Mountain Crest Acquisition 6 Corp. — Q3 2026 Form 10-Q
Period: Quarter ended September 30, 2026; unaudited. The company is a blank-check company incorporated in the British Virgin Islands, formed to pursue a business combination. It had not selected a target or begun substantive discussions with a potential target by quarter-end.
Financial position and results
- Revenue: No operating revenue; the company expects none until after a business combination. Revenue margins are not applicable.
- Q3 net income: $495,403, comprising $551,328 of trust-account interest less $55,925 of formation, general and administrative costs. No income tax provision was recorded.
- Inception-to-date net income: $800,577, including $888,904 of trust interest and a $47,300 gain from the change in fair value of the over-allotment liability, offset by $135,627 of costs. The over-allotment option expired unexercised in June.
- Assets and liquidity: Total assets were $60.9 million, including $60.9 million in the trust account and only $1,701 of cash outside the trust. Current assets were $31,943 versus current liabilities of $500,670, a $468,727 working-capital deficit.
- Debt: $423,670 outstanding under an unsecured, non-interest-bearing related-party promissory note, due at the earlier of a business-combination closing or the decision not to proceed. No working-capital or extension loans were outstanding.
- Cash flows, inception through September 30: $63,869 used in operating activities; $60.0 million used in investing activities to fund the trust; and $60.1 million provided by financing activities. Q3-only cash flow is not provided.
- Equity and redemption: 6.0 million public shares were classified as temporary equity at $60.9 million, or approximately $10.15 per share. Shareholders’ deficit was $468,727. There were 8,661,429 ordinary shares issued and outstanding as of November 13, 2026.
Changes, outlook and risks
- The filing does not provide prior-year quarterly results for comparison. It reports Q3 results and inception-to-date results; therefore, year-over-year trends cannot be assessed from this filing.
- The company completed its $60.0 million IPO on May 1, 2026. The over-allotment option expired unexercised on June 15, resulting in forfeiture of 385,714 founder shares.
- The initial business-combination deadline is 12 months after the IPO closing, with up to two optional three-month extensions, for a maximum of 18 months. Each extension requires a $600,000 sponsor or affiliate deposit into the trust; funding is not assured or obligated.
- Management states that cash outside the trust is insufficient to sustain operations for one year and that the deadline for completing a business combination, and potential liquidation, raise substantial doubt about the company’s ability to continue as a going concern. No assurance is given that a transaction will be completed on time.
- Key risks include finding a suitable target, shareholder redemptions, obtaining additional financing, sponsor and management conflicts, investment-company status, and maintaining Nasdaq listing. Market volatility and geopolitical and trade uncertainty may also affect transaction financing or a target’s operations.
- Trust assets may be subject to creditor claims. The sponsor’s trust-protection indemnity has exceptions, and the company has not verified the sponsor’s ability to meet it. If no business combination is completed within the permitted period, public shares are to be redeemed; rights expire worthless.
- No material change to previously disclosed risk factors, no legal proceedings, and no material subsequent events were reported. Management concluded disclosure controls were effective; no material change in internal control was reported.
Important facts for investors to verify
- Whether a target has been identified, and the remaining time and funding required to complete a transaction.
- The company’s very limited unrestricted cash, working-capital deficit, and access to sponsor or other financing.
- Whether the sponsor will fund either optional extension and the resulting impact on trust value and the business-combination deadline.
- Potential redemptions, creditor claims against trust assets, and the sponsor’s capacity to honor its indemnity.
- Transaction-related dilution and costs, including the underwriter’s 150,000 deferred compensation shares upon a business-combination closing and the shares issuable on rights conversion.